SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-16-111852
Filing Date
2016-04-15
Accepted
2016-04-15 16:36:43
Documents
2
Group Members
CETUS CAPITAL III, L.P.LITTLEJOHN OPPORTUNITIES MASTER FUND LPSG DISTRESSED FUND, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a16-8537_1sc13da.htm SC 13D/A 181231
2 EX-99.1 a16-8537_1ex99d1.htm EX-99.1 15785
  Complete submission text file 0001104659-16-111852.txt   198791
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50927 | Film No.: 161574860
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 SOUND SHORE DRIVE SUITE 303 GREENWICH CT 06830
Business Address 8 SOUND SHORE DRIVE SUITE 303 GREENWICH CT 06830 (203) 552-3500
Cetus Capital II, LLC (Filed by) CIK: 0001561987 (see all company filings)

IRS No.: 270433185 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A